Cargando…
OMRT-2. Liquid biopsy for patient stratification and monitoring of dacomitinib clinical trial in patients with EGFR amplified recurrent glioblastoma
INTRODUCTION: Liquid biopsy for the detection and monitoring of brain tumors is of significant clinical interest. The ability to non-invasively profile tumors can avoid a risky biopsy and opens avenues for testing novel therapies by accurately stratifying patients to receive the right therapy. Here,...
Autores principales: | Yekula, Anudeep, Kitchen, Robert, Chakrabortty, Sudipto, Carter, Bob, Breakefield, Xandra, Skog, Johan, Balaj, Leonora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255422/ http://dx.doi.org/10.1093/noajnl/vdab070.028 |
Ejemplares similares
-
Longitudinal analysis of serum-derived extracellular vesicle RNA to monitor dacomitinib treatment response in EGFR-amplified recurrent glioblastoma patients
por: Yekula, Anudeep, et al.
Publicado: (2023) -
Extracellular Vesicles in Glioblastoma Tumor Microenvironment
por: Yekula, Anuroop, et al.
Publicado: (2020) -
OMRT-11. The effect of microenvironment on glioblastoma stem cells therapeutic resistance
por: Turnsek, Tamara Lah, et al.
Publicado: (2021) -
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls
por: Noerholm, Mikkel, et al.
Publicado: (2012) -
OMRT-12. Nanoparticle-based CRISPR-Cas9 delivery for anti-glioblastoma immunotherapy
por: Aguilar, Rocio, et al.
Publicado: (2021)